Rubicon Research Limited — Thane
USFDA inspection record for FEI 3008252295, Thane, India.
NAI
Latest classification
3
Inspections on record
1
Form 483 observations on record
History (newest first)
Inspections
07 Nov 2024
NAI — No action indicated
Postmarket Assurance: Devices · Devices · FY2025
Source: FDA Data Dashboard ↗
08 Mar 2024
27 Jan 2023
VAI — Voluntary action indicated
Drug Quality Assurance · Drugs · FY2023
Form 483: 1 observation
- In-process materials characteristics testing (21 CFR 211.110(c))
Source: FDA Data Dashboard ↗
📎 Cite this data: Source: PharmaRoz, FDA inspection record for FEI 3008252295, updated 12 Nov 2026